Home » Topics » Regulatory » Patents

Patents
RSS

ViiV Healthcare UK patents novel HIV integrase inhibitors

Dec. 5, 2017

Stanford University describes novel adrenergic receptor modulators

Dec. 5, 2017

Istituto Europeo di Oncologia describes novel KDM4C inhibitors

Dec. 4, 2017

Enanta Pharmaceuticals presents novel farnesoid X receptor agonists

Dec. 4, 2017

Prolyl endopeptidase inhibitors identified at Bayer

Dec. 4, 2017

New proteolysis targeting chimera compounds presented by C4 Therapeutics

Dec. 4, 2017

Femtogenix synthesizes novel anticancer conjugate compounds

Dec. 4, 2017

Enanta patents novel farnesoid X receptor agonists

Dec. 1, 2017

Novel AMP-activated protein kinase activators generated at Shionogi

Dec. 1, 2017

Luoda Biosciences and Nanjing Shiqi Pharmaceutical describe novel anticancer compounds

Dec. 1, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...